Advisor
Advisor ❌

Subscribe

Please type this word to confirm you're human:

Direct contact method with new technical steps essential to detect cytotoxicity of a volatile substance. Medical device quality assurance.

Girish K Srivastava 1,2, Maria T Garcia 3, José Carlos Pastor 1,2,4

  1. Instituto Universitario de Oftalmobiologia Aplicada (IOBA), Universidad de Valladolid, Valladolid, Spain.
  2. Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León, Spain.
  3. Vision R+D. Valladolid. Spain
  4. Hospital Clinico Universitario de Valladolid, Valladolid, Spain

Abstract

Medical devices need to pass ISO recommended safety assessments before clinical use. Perfluorocarbon liquids (PFOs) are used in intraocular surgery. Recent cases of blindness raised questions against current cytotoxicity test methods applied for safety assessments of PFOs. The study proposes to assess the cell culture responses to different PFOs by applying a direct contact method incorporating few new technical steps for testing volatile substances such as PFOs. Limitations of current methods; extract dilution exposure and agarose overlay methods, were recorded. ARPE-19 cell cultures were prepared, and the direct contact and extract dilution exposure methods were performed for different PFOs. Agarose overlay method was performed partially. Results showed that for non-toxic PFOs, the ARPE-19 cell cultures showed different tendencies of growths at 24 and 72 hours for PFOs of different manufacturers maintaining always cell viability ≥ 70%; however, the difference was not significant for PFOs of a same manufacturer. The toxic PFOs were detected toxic which extract dilution exposure method failed to detect. There were several limitations detected in applying the current cytotoxicity test methods. One crucial limitation was that it was unknown if a quantity of PFO or toxicity components of PFO reached in contact with cell culture, which was not in the case of new direct contact method. It has detected non-toxic and toxic PFOs lots which were manufactured differently. The study strengthens the arguments that a direct cytotoxicity method with the new technical steps is essential for safety assessments of volatile substances and guaranteeing safety of such medical devices.

Keywords: Medical device quality assurance, Direct contact method, Cytotoxicity, Volatile substances

References

  1. Becker, R.A., Janus, E.R., White, R.D., Kruszewski, F.H., and Brackett, R.E. (2009). Good laboratory practices and safety assessments. Environ. Health Perspect. 117, A482-483; author reply A483-484.
  2. Bentley, D. (1999). CE marking--what does it really mean? J. Tissue Viability 9, 11–15.
  3. Bollen, L.S. (2005). New trends in biological evaluation of medical devices. Med. Device Technol. 16, 10–15.
  4. Donawa, M. (2003). Review of the Medical Device Directive. Med. Device Technol. 14, 20–23.
  5. Donawa, M.E. (1997). Complying with US and European complaint handling requirements. Med. Device Technol. 8, 12–15.
  6. Eckardt, C., Nicolai, U., Winter, M., and Knop, E. (1991). Experimental intraocular tolerance to liquid perfluorooctane and perfluoropolyether. Retina Phila. Pa 11, 375–384.
  7. Helmus, M.N., Gibbons, D.F., and Cebon, D. (2008). Biocompatibility: meeting a key functional requirement of next-generation medical devices. Toxicol. Pathol. 36, 70–80.
  8. Lamph, S. (2012). Regulation of medical devices outside the European Union. J. R. Soc. Med. 105 Suppl 1, S12-21.
  9. Li, W., Zhou, J., and Xu, Y. (2015). Study of the in vitro cytotoxicity testing of medical devices. Biomed. Rep. 3, 617–620.
  10. Pastor, J.C., Coco, R.M., Fernandez-Bueno, I., Alonso-Alonso, M.L., Medina, J., Sanz-Arranz, A., Rull, F., Gayoso, M.J., Dueñas, A., Garcia-Gutierrez, M.T., et al. (2017). Acute Retinal Damage After Using A Toxic Perfluoro-Octane For Vitreo-Retinal Surgery. Retina Phila. Pa 37, 1140–1151.
  11. Peyman, G.A., Schulman, J.A., and Sullivan, B. (1995). Perfluorocarbon liquids in ophthalmology. Surv. Ophthalmol. 39, 375–395.
  12. Reeve, L., and Baldrick, P. (2017). Biocompatibility assessments for medical devices - evolving regulatory considerations. Expert Rev. Med. Devices 14, 161–167.
  13. Schuh, J.C.L. (2008). Medical device regulations and testing for toxicologic pathologists. Toxicol. Pathol. 36, 63–69.
  14. Simons, J.H., and Harland, W.J. (1949). Production of Fluorocarbons III. From Hydrogen Fluoride-Soluble Organic Substances. J Electrochem Soc 95, 55–59.

Publication

Ms. Ref. No.: AllBios-A0101004    Reviewer 1    Reviewer 2

Received: 01-07-2017

Accepted: 02-12-2017

Article in Press: 03-12-2017

Published Online: 18-12-2017

How to cite this paper